Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
However, if considered for weight management in someone with active Crohn's disease or malnutrition, alternative approaches would typically be preferred
That combination is reliable for most people, though individual circumstances will always matter
This approval is another important step in helping people living with obesity reach very significant weight loss, said Emil Kongshj Larsen, executive vice president, International Operations, Novo Nordisk, in a press release
A meta-analysis of the effect of glucagon-like peptide-1 (736) amide on ad libitum energy intake in humans
Important note about Ozempic: Novo Nordisk charges self-pay patients $499 a month for 2-mg of Ozempicthats $150 more than they charge for a 2.5-mg dose of Wegovy, which is the exact same drug
